Remove 2023 Remove Insurance Remove Vaccines
article thumbnail

Fragmented Policy, Insurance Landscape Challenges Newly Approved Vaccines

Drug Topics

Innovation in the vaccine area continues. In 2023, the FDA approved six vaccines, including several important firsts. But they face a difficult landscape where federal policies dictate coverage.

Vaccines 461
article thumbnail

CDC advisory panel opts for a go-slow approach on expanding usage of RSV vaccines

STAT

Makers of RSV vaccines for older adults saw their plans to try to expand usage hit a significant hurdle on Wednesday, when an expert committee that advises the Centers for Disease Control and Prevention on vaccines recommended changes that will likely see fewer older adults qualify for insurance coverage for these products.

Vaccines 126
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Everything you need to know about the RSV vaccine

The Checkup by Singlecare

This year, there are new vaccines to help at-risk populations ward off severe sickness, including that caused by RSV. Here’s what you need to know about the new FDA-approved RSV vaccine. Is there a vaccine for RSV? Not all vaccines work via the same science. Is there an RSV vaccine for children? What is RSV?

Vaccines 105
article thumbnail

Pfizer plans considerable 2023 Comirnaty markup

pharmaphorum

With US government supplies of Covid vaccines predicted to run out in the first quarter of 2023, it has been revealed that Pfizer/BioNTech plans to charge as much as $130 for its Covid vaccine, Comirnaty, once Covid vaccines and therapeutics are moved onto commercial health platforms. billion in vaccine production.

article thumbnail

STAT+: Pharmalittle: Pfizer plans to quadruple price of its Covid-19 vaccine; pharma pushed to tie exec compensation to access to meds

STAT

… Pfizer expects to roughly quadruple the list price of its Covid-19 vaccine to about $110 to $130 per dose after the U.S. Wall Street was expecting such price hikes due to weak demand for Covid shots, which meant vaccine makers would need to hike prices to meet revenue forecasts for 2023 and beyond.

article thumbnail

What Pharmacists Should Know About Medicare Open Enrollment 2023

Digital Pharmacist

The Medicare Open Enrollment period for 2023 is quickly approaching – this is a critical time for both your patients and your pharmacy. This leaves very little time before patients need to re-evaluate their insurance. . About Medicare Open Enrollment 2023. Anticancer drugs (unless covered by Part B). References: .

article thumbnail

Does Medicaid cover Shingrix?

The Checkup by Singlecare

Shingrix is a very effective vaccine recommended for adults 50 and older and those with weakened immune systems. Starting in 2023, the Inflation Reduction Act of 2022 made vaccines more accessible for Medicare and Medicaid recipients. Without insurance, Medicare, or Medicaid, Shingrix costs over $500 for both doses.